FindTrial
Sign In

The application of 68Ga-FAPI and 18F-FDG PET/CT in the diagnosis of ovarian cancer

The application of 68Ga-FAPI and 18F-FDG PET/CT in the diagnosis of ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066556
Enrollment
Unknown
Registered
2022-12-08
Start date
2022-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Gold Standard:pathology(surgical or puncture pathology)and/or imaging follow-up
Index test:Imaging results of 68Ga-FAPI and 18F-FDG PET/CT in patients with newly diagnosed or recurrent ovarian cancer

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) both [18F]-FDG and [68Ga]-FAPI PET/CT were performed; (2) signed informed consent; (3) adult patients (age > 18); (4) pathologically confirmed primary or relapsed ovarian cancer

Exclusion criteria

Exclusion criteria: (1) women with ovarian cancer who planned to become pregnant within 6 months,or were pregnant or lactating were excluded. (2) patients with other malignant tumors (3) ruling out ovarian cancer (4) poor performance status (5) patients who refused to undergo [18F]-FDG or [68Ga]-FAPI PET/CT or provide informed consent.

Design outcomes

Primary

MeasureTime frame
sensitivity;—

Secondary

MeasureTime frame
specificity;accuracy;—

Countries

China

Contacts

Public ContactShaoli Song

Fudan University Shanghai Cancer Center

shaoli-song@163.com13816608573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026